Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone in long term prophylaxis.

D Katritsis1, A J Camm

  • 1Department of Cardiological Sciences, St. George's Hospital Medical School, London, England.

Drugs
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse effects of amiodarone at low dose: plus ça change.

Journal of the American College of Cardiology·1997
Same author

Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system.

Pacing and clinical electrophysiology : PACE·1997
Same author

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.

Japanese circulation journal·1997
Same author

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Circulation·1997
Same author

Chlamydia pneumoniae and coronary heart disease.

BMJ (Clinical research ed.)·1997
Same author

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.

Lancet (London, England)·1997
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Amiodarone effectively treats refractory ventricular arrhythmias in 50-60% of patients. However, its efficacy in preventing cardiac arrest and ventricular tachycardia requires more controlled studies for definitive evidence.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Amiodarone is a Group III antiarrhythmic agent, primarily a potassium channel inhibitor.
  • It also exhibits sodium channel blockade, calcium channel blockade, and adrenergic receptor inhibition.

Purpose of the Study:

  • To evaluate the efficacy of amiodarone in treating refractory ventricular arrhythmias.
  • To identify the need for further controlled studies on amiodarone's effectiveness.

Main Methods:

  • Review of existing studies on amiodarone for ventricular arrhythmias.
  • Analysis of treatment success rates and comparison with placebo or other antiarrhythmics.

Main Results:

  • Successful treatment of refractory ventricular arrhythmias with amiodarone observed in 50-60% of patients within the first year.

Related Experiment Videos

  • Limited prospective randomized studies exist to compare amiodarone's efficacy against placebo or other antiarrhythmic drugs.
  • Controlled studies on amiodarone's impact on preventing ventricular tachycardia in cardiac arrest survivors are lacking.

    • Conclusions:

    • While amiodarone shows promise in treating refractory ventricular arrhythmias, robust evidence from controlled trials is needed.
    • Further research is essential to establish amiodarone's definitive role in preventing sudden cardiac death and managing ventricular arrhythmias in specific patient populations.